Sugammadex Hypersensitivity Study (Study P06042)

Clinical trial NCT00988065 · COMPLETED

Trial details

NCT number: NCT00988065
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypersensitivity

Start date: 2009-09-06
Primary completion: 2010-04-13
Enrollment: 448

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.